The Central Misunderstanding

Many peptide certificates of analysis prominently display a result such as “Purity: 99.1%”. Because the number is close to 100%, readers may assume it means the vial contains nearly 100% of the peptide amount printed on the label. That is usually not what the number means.

In many cases, the reported purity is an HPLC or UPLC chromatographic area percentage. It describes the relative area of the main detected peak compared with the total included detected peak area under that method. It is primarily a statement about the composition of the detected chromatographic material—not a direct measurement of the total milligrams in the vial.

A vial can contain a small amount of very clean peptide. It can also contain the expected total amount of peptide with a less favorable impurity profile. A complete evaluation requires both purity information and a suitable quantitative assay.

What Does “99% Pure” Usually Mean?

For many synthetic peptide reports, purity is measured using reversed-phase high-performance liquid chromatography, commonly abbreviated RP-HPLC. The laboratory dissolves a portion of the material, injects it into the chromatographic system, separates detectable components, and records peaks as they leave the column.

The main peak is generally assigned to the target peptide using retention behavior, a reference material, mass spectrometry, or another identity-supporting procedure. The instrument software calculates the area under the main peak and compares it with the total area of other included peaks.

If the main peak represents 99% of the integrated area, the report may state 99% purity by HPLC area normalization. This can be valuable information. It can indicate that relatively little chromatographically detected related material appeared outside the main peak under the stated method.

However, the result is limited by what the method can separate, what the detector can see, how the integration was performed, the wavelength used, the reporting threshold, and whether all relevant components produced comparable detector responses.

What the 99% number may support

• The main detected component dominated the chromatogram.
• Detected related peptide impurities were relatively limited under that method.
• The sample may have undergone effective synthesis and purification.
• The chromatographic result met a stated purity specification, when one was defined.

What the 99% number does not automatically prove

• The vial contains the labeled milligrams.
• The main peak is definitely the correct peptide without identity support.
• The material is sterile.
• Bacterial endotoxins are absent.
• Residual solvents, metals, counterions, or water are within limits.
• The same result applies to every vial in the batch.
• The material is approved or suitable for human use.

How Can a Highly Pure Peptide Be Underfilled?

The easiest way to understand the issue is to separate cleanliness from amount.

Imagine two sealed containers of laboratory-grade sugar. One contains 100 grams, and the other contains only 70 grams. If both samples are 99.5% chemically pure, the smaller container is still underfilled relative to a 100-gram label. Its purity did not change simply because less material was placed in the container.

The same principle applies to peptides. A vial labeled “10 mg” could contain 7 mg of peptide that is 99% chromatographically pure. The peptide material may be relatively clean, but the quantity claim would still be inaccurate.

In all three examples, the relative purity can be identical. The only difference is how much peptide is present. That amount must be measured using a quantitative method rather than inferred from chromatographic purity.

Common reasons an underfill can occur

Why HPLC Area Percent Is Not a Milligram Measurement

An HPLC ultraviolet detector records signal intensity as compounds pass through it. The resulting chromatogram shows relative detector response over time. When purity is calculated by area normalization, the software divides the main-peak area by the combined area of included peaks.

The calculation does not inherently know whether the vial contained 5 mg, 10 mg, or 20 mg before the sample was diluted. Laboratories commonly prepare test solutions at a chosen concentration so the signal fits the analytical range of the instrument. A small vial and a large vial can both be diluted to produce similar test-solution concentrations and nearly identical chromatograms.

Area percent is relative

Suppose a chromatogram contains:

This tells us the relative distribution of included detector signal. It does not tell us the absolute mass of peptide in the original vial unless the method also includes a valid quantitative calibration and sample-preparation calculation.

Not every component responds equally

Area normalization often assumes that the main peptide and detected impurities produce sufficiently comparable detector responses at the selected wavelength. That assumption may be imperfect. Different sequences or modifications can absorb ultraviolet light differently. Components that do not absorb strongly at the chosen wavelength may be underestimated or missed.

Water, many salts, some excipients, and certain non-UV-active contaminants may not appear as meaningful peaks. Therefore, 99% HPLC area purity should not be interpreted as meaning that 99% of the total dry cake’s physical mass is the target peptide.

Dilution can hide the original quantity from view

Consider two vials:

• Vial A contains 5 mg of peptide.
• Vial B contains 10 mg of peptide.

If the laboratory prepares both at a final analytical concentration of 1 mg/mL and injects the same volume, their HPLC purity chromatograms could look nearly identical. The chromatogram compares composition at the prepared concentration. It does not retain an automatic memory of how much total peptide was originally in each vial.

What Test Actually Measures Peptide Quantity?

A quantitative assay or content determination is needed to evaluate how much peptide is present. The method must be appropriate for the intended measurement and should use suitable reference materials, calibrated instrument response, controlled sample preparation, defined calculations, and appropriate validation or scientific qualification.

FDA describes assay as a test of how much drug is present and whether it is consistent with the labeled amount. That is fundamentally different from asking whether related impurities are within specification.

Common quantitative approaches

A quantitative HPLC assay is not the same as an HPLC purity run

The same broad instrument category can be used for different purposes. One HPLC method may calculate relative impurity area percentages. Another may quantify peptide concentration against a reference-standard calibration curve. A COA that merely says “HPLC” is incomplete unless it identifies whether the method was used for identity, purity, assay, or another purpose.

Reference-standard quality is critical

A standard used for quantitative testing must have an assigned value appropriate for assay use. It cannot safely be assumed to be 100% peptide by mass. Reference materials can contain moisture, counterions, residual solvents, inorganic material, and chromatographic impurities. USP specifically notes that a value of 100% cannot be assumed for a reference standard unless an assigned value is provided.

If a laboratory weighs 1.00 mg of a reference material that is only 85% peptide on an as-is basis but treats it as 100%, the resulting assay can be biased. Correct potency assignment and calculation are therefore essential.

Total Cake Weight Is Not Necessarily Net Peptide Content

Another common misunderstanding is that weighing the dried contents of a vial proves the peptide quantity. The visible cake may contain more than the target peptide.

Gross vial content or total dry weight can include every nonvolatile component remaining after lyophilization. Net peptide content is the actual amount of the intended peptide, calculated or measured on a clearly defined basis.

Why weighing alone can mislead

Assume a vial’s dry cake weighs 12 mg. That does not necessarily mean it contains 12 mg of peptide. The composition might include:

In this example, the cake weighs more than the 10 mg label claim, yet the vial is still underfilled with respect to target peptide. The extra physical mass comes from other components.

Why cake size is even less reliable than cake weight

Cake volume is affected by formulation concentration, excipients, freezing rate, nucleation, collapse temperature, vial dimensions, vacuum conditions, and drying parameters. Two vials containing the same peptide quantity can look dramatically different. A taller or fluffier cake is not proof of more peptide.

Excipients, Water, Salts, and Counterions

To understand net peptide content, it helps to know what else may be present in a synthetic peptide material or lyophilized vial.

“As is,” “anhydrous,” and “salt-free” are not interchangeable

A peptide result may be reported on different bases:

• As-is basis: reflects the material in its tested condition, including applicable water and counterions.
• Anhydrous basis: mathematically corrects for measured water.
• Salt-free or free-peptide basis: corrects for counterions when appropriate.
• Purity-corrected basis: adjusts for measured related impurities.
• Percent of label claim: compares the measured amount with the nominal amount printed on the vial.

A number without a clearly stated basis can be easily misunderstood. “10.0 mg” should prompt the question: 10.0 mg of total dried material, peptide salt, free peptide equivalent, or target peptide after corrections?

Worked Examples for a Vial Labeled 10 mg

Example 1: High purity, true underfill

The purity result does not cancel the underfill. Both statements can be true simultaneously.

Example 2: Correct total cake weight, peptide underfill

Example 3: Purity looks lower, quantity is correct

Quantity compliance does not erase an impurity concern. Purity and assay must each be evaluated against appropriate specifications.

Example 4: Only purity was tested

Example 5: Percent assay requires context

Sampling Matters: One Good Vial Does Not Prove the Entire Batch

Even a well-designed quantitative assay applies directly only to the sample that was tested. If one vial from a batch of 1,000 is analyzed, the result proves what was found in that vial. It does not mathematically establish that every other vial contains the same amount.

Confidence in batch uniformity depends on:

• The accuracy and precision of the filling process
• Bulk-solution mixing and homogeneity
• Controls for concentration before and during filling
• Equipment calibration and in-process monitoring
• The number of finished vials sampled
• Whether sampling was random and representative
• Whether vials from different points in the run were tested
• Whether results were averaged in a way that could conceal individual underfills

Bulk powder testing does not prove finished-vial content

A manufacturer may test the purity and identity of bulk peptide powder before formulation. That report can provide useful information about the raw material, but it does not establish that each finished vial received the correct peptide amount. Filling, formulation, transfer, and lyophilization occur after the bulk powder stage and introduce additional opportunities for variation.

An average can hide individual failures

Suppose three vials contain 8 mg, 10 mg, and 12 mg. Their average is 10 mg, but two of the three individual vials differ substantially from the nominal amount. A report should state whether the result is a single-vial value, an average, a composite sample, or a range across individual units.

How COA Language Can Create False Confidence

A COA does not need to contain an outright false statement to mislead. Ambiguous terminology, selective formatting, or unsupported marketing conclusions can cause readers to infer more than the data show.

Terms that require clarification

How to Verify a Peptide Milligram Claim

When a vial is labeled with a specific amount, look for evidence that directly addresses that quantity. The following review process helps separate a real content measurement from a purity result being used as a substitute.

1. Match the lot number. Confirm that the report applies to the exact batch or lot printed on the vial. A test from a different batch does not verify the current product.
2. Find a separate quantitative result. Look for “assay,” “peptide content,” “content per vial,” “percent of label claim,” or another clearly quantitative result—not only “purity.”
3. Identify the method’s purpose. Determine whether HPLC was used for relative purity or calibrated quantity. The method description should make this clear.
4. Check the units. A useful content result should state units such as mg/vial, mg/mL, or percent of a defined label claim.
5. Check the reporting basis. Determine whether the result is as-is, anhydrous, salt-free, free-peptide equivalent, or corrected for standard potency and chromatographic purity.
6. Review the reference standard. Confirm that the standard was suitable for quantitative use and had an assigned potency or content value.
7. Review sample preparation. The report should account for the entire vial, dilution volumes, transfer recovery, and calculations needed to convert instrument response into total vial content.
8. Ask how many vials were tested. One vial, multiple individual vials, and a pooled composite sample provide different levels of information.
9. Look for a specification. A result should be compared with a predefined acceptable range rather than merely declared “pass.”
10. Keep purity separate. Evaluate the impurity profile and quantitative content as two independent results that both matter.

What a stronger testing packet looks like

• Identity supported by mass spectrometry or another suitable method
• Chromatographic purity with full chromatogram and integration table
• Quantitative peptide content reported in mg per vial
• Reference-standard identity and assigned potency documented
• Clear corrections for water, counterions, and other relevant components
• Multiple finished vials sampled across the filling run
• Individual results or variability statistics, not only a pooled average
• Lot-specific report from a verifiable laboratory
• Separate testing for other relevant quality attributes

Purity, Identity, Quantity, and Safety Answer Different Questions

Frequently Asked Questions

Final Takeaway

A peptide can be 99% chromatographically pure and still be substantially underfilled because purity describes the relative composition of detected material, while assay measures how much target peptide is present. One result cannot replace the other.

The most credible peptide testing does not rely on a single impressive percentage. It combines identity testing, a suitable purity method, a properly calibrated quantitative assay, clear reporting units, appropriate reference standards, transparent calculation bases, and representative finished-vial sampling.